With only a few episodes of "The Traitors" Season 3 left, a final showdown between "Survivor" finalist Carolyn Wiger and "Big Brother" finalist Danielle Reyes was only a matter of time.

Carolyn Wiger. That’s part of the reason as to why the “Survivor 44” star experienced some slight “imposter syndrome” when she entered Alan Cumming’s Scottish castle, only to find ...

Some employers and foreign nationals may have to wait on pursuing provincial nominations for permanent residency from Saskatchewan. The SINP announced a temporary pause on all new Job Approval Forms ...

Canada's Minister of Agriculture and Agri-Food, Lawrence MacAulay, and Saskatchewan Agriculture Minister, Daryl Harrison, have announced continued funding and commitment through the 2025 Crop ...

The 2025 theme for Black History Month is Black legacy and leadership. CBC Saskatchewan is profiling local leaders whose work not only honours the legacy of past Black activists, but also ...

Dear Carolyn: My mom died six years ago ... wasn’t nice enough and he’d booked a vacation home on a different lake. I looked at it and the fishing isn’t good; they don’t allow dogs ...

(RTTNews) - bluebird bio, Inc. (BLUE) announced Friday that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle Group, Inc. (CG) and SK ...

The segment saw the tensions between Danielle and Carolyn rise as the two went against one another at the roundtable. The two accused each other of being traitors, however, eventually, Danielle ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $30 million, in a deal that lets the beleaguered ...

Carlyle and SK Capital are looking forward to accelerating bluebird's growth and continuing its mission to deliver therapies that improve patient outcomes. Legal advisors for the transaction ...

Carlyle and SK Capital will provide bluebird primary capital to scale bluebird’s commercial delivery of gene therapies for patients with sickle cell disease, β-thalassemia, and cerebral ...